284 related articles for article (PubMed ID: 28536426)
21. Stimulated myotube contractions regulate membrane-bound and soluble TLR4 to prevent LPS-induced signaling and myotube atrophy in skeletal muscle cells.
Ducharme JB; Fennel ZJ; McKenna ZJ; Nava RC; Deyhle MR
Am J Physiol Cell Physiol; 2023 Jul; 325(1):C300-C313. PubMed ID: 37335026
[TBL] [Abstract][Full Text] [Related]
22. TLR4 activation is required for IL-17-induced multiple tissue inflammation and wasting in mice.
Tang H; Pang S; Wang M; Xiao X; Rong Y; Wang H; Zang YQ
J Immunol; 2010 Aug; 185(4):2563-9. PubMed ID: 20631308
[TBL] [Abstract][Full Text] [Related]
23. Activin A induces skeletal muscle catabolism via p38β mitogen-activated protein kinase.
Ding H; Zhang G; Sin KW; Liu Z; Lin RK; Li M; Li YP
J Cachexia Sarcopenia Muscle; 2017 Apr; 8(2):202-212. PubMed ID: 27897407
[TBL] [Abstract][Full Text] [Related]
24. p38β MAPK mediates ULK1-dependent induction of autophagy in skeletal muscle of tumor-bearing mice.
Liu Z; Sin KWT; Ding H; Doan HA; Gao S; Miao H; Wei Y; Wang Y; Zhang G; Li YP
Cell Stress; 2018 Oct; 2(11):311-324. PubMed ID: 31225455
[TBL] [Abstract][Full Text] [Related]
25. S-allyl cysteine inhibits TNFα-induced skeletal muscle wasting through suppressing proteolysis and expression of inflammatory molecules.
Dutt V; Saini V; Gupta P; Kaur N; Bala M; Gujar R; Grewal A; Gupta S; Dua A; Mittal A
Biochim Biophys Acta Gen Subj; 2018 Apr; 1862(4):895-906. PubMed ID: 29288771
[TBL] [Abstract][Full Text] [Related]
26. Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole.
Liu Z; Xiong J; Gao S; Zhu MX; Sun K; Li M; Zhang G; Li YP
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):636-647. PubMed ID: 34729960
[TBL] [Abstract][Full Text] [Related]
27. Diet-induced obesity does not exacerbate cachexia in male mice bearing Lewis-lung carcinoma tumors.
Beaudry AG; Law ML; Gilley-Connor KR; Buley H; Dungan CM; Nascimento CMC; Vichaya EG; Wiggs MP
Am J Physiol Regul Integr Comp Physiol; 2024 Mar; 326(3):R254-R265. PubMed ID: 38252513
[TBL] [Abstract][Full Text] [Related]
28. REDD1 deletion attenuates cancer cachexia in mice.
Hain BA; Xu H; VanCleave AM; Gordon BS; Kimball SR; Waning DL
J Appl Physiol (1985); 2021 Dec; 131(6):1718-1730. PubMed ID: 34672766
[TBL] [Abstract][Full Text] [Related]
29. Chronic Alcohol Consumption Enhances Skeletal Muscle Wasting in Mice Bearing Cachectic Cancers: The Role of TNFα/Myostatin Axis.
Li Y; Zhang F; Modrak S; Little A; Zhang H
Alcohol Clin Exp Res; 2020 Jan; 44(1):66-77. PubMed ID: 31657476
[TBL] [Abstract][Full Text] [Related]
30. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.
Bonetto A; Aydogdu T; Jin X; Zhang Z; Zhan R; Puzis L; Koniaris LG; Zimmers TA
Am J Physiol Endocrinol Metab; 2012 Aug; 303(3):E410-21. PubMed ID: 22669242
[TBL] [Abstract][Full Text] [Related]
31. TAK-242, a specific inhibitor of Toll-like receptor 4 signalling, prevents endotoxemia-induced skeletal muscle wasting in mice.
Ono Y; Maejima Y; Saito M; Sakamoto K; Horita S; Shimomura K; Inoue S; Kotani J
Sci Rep; 2020 Jan; 10(1):694. PubMed ID: 31959927
[TBL] [Abstract][Full Text] [Related]
32. TLR4 signaling pathway in mouse Lewis lung cancer cells promotes the expression of TGF-β1 and IL-10 and tumor cells migration.
Li C; Li H; Jiang K; Li J; Gai X
Biomed Mater Eng; 2014; 24(1):869-75. PubMed ID: 24211974
[TBL] [Abstract][Full Text] [Related]
33. LP07 and LLC preclinical models of lung cancer induce divergent anabolic deficits and expression of pro-inflammatory effectors of muscle wasting.
Belcher DJ; Guitart M; Hain B; Kim HG; Waning D; Barreiro E; Nader GA
J Appl Physiol (1985); 2022 Dec; 133(6):1260-1272. PubMed ID: 36201324
[TBL] [Abstract][Full Text] [Related]
34. Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease.
Verzola D; Bonanni A; Sofia A; Montecucco F; D'Amato E; Cademartori V; Parodi EL; Viazzi F; Venturelli C; Brunori G; Garibotto G
J Cachexia Sarcopenia Muscle; 2017 Feb; 8(1):131-144. PubMed ID: 27897392
[TBL] [Abstract][Full Text] [Related]
35. Lung cancer-derived extracellular vesicles induced myotube atrophy and adipocyte lipolysis via the extracellular IL-6-mediated STAT3 pathway.
Hu W; Ru Z; Zhou Y; Xiao W; Sun R; Zhang S; Gao Y; Li X; Zhang X; Yang H
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Aug; 1864(8):1091-1102. PubMed ID: 31002945
[TBL] [Abstract][Full Text] [Related]
36. Transcriptomic analysis of the development of skeletal muscle atrophy in cancer-cachexia in tumor-bearing mice.
Blackwell TA; Cervenka I; Khatri B; Brown JL; Rosa-Caldwell ME; Lee DE; Perry RA; Brown LA; Haynie WS; Wiggs MP; Bottje WG; Washington TA; Kong BC; Ruas JL; Greene NP
Physiol Genomics; 2018 Dec; 50(12):1071-1082. PubMed ID: 30289747
[TBL] [Abstract][Full Text] [Related]
37. Reduced sucrose nonfermenting AMPK-related kinase (SNARK) activity aggravates cancer-induced skeletal muscle wasting.
Alves CRR; MacDonald TL; Nigro P; Pathak P; Hirshman MF; Goodyear LJ; Lessard SJ
Biomed Pharmacother; 2019 Sep; 117():109197. PubMed ID: 31387190
[TBL] [Abstract][Full Text] [Related]
38. Myostatin gene inactivation prevents skeletal muscle wasting in cancer.
Gallot YS; Durieux AC; Castells J; Desgeorges MM; Vernus B; Plantureux L; Rémond D; Jahnke VE; Lefai E; Dardevet D; Nemoz G; Schaeffer L; Bonnieu A; Freyssenet DG
Cancer Res; 2014 Dec; 74(24):7344-56. PubMed ID: 25336187
[TBL] [Abstract][Full Text] [Related]
39. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia.
Shukla SK; Markov SD; Attri KS; Vernucci E; King RJ; Dasgupta A; Grandgenett PM; Hollingsworth MA; Singh PK; Yu F; Mehla K
Cancer Lett; 2020 Aug; 484():29-39. PubMed ID: 32344015
[TBL] [Abstract][Full Text] [Related]
40. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
